½ÃÀ庸°í¼­
»óǰÄÚµå
1594433

ÁÖ»ç¹Ù´Ã ½ÃÀå : Á¦Ç° À¯Çüº°, ÃÖÁ¾»ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Needle Market by Product (Blood Collection Needles, Dental Needles, Ophthalmic Needles), Type (Active Needles, Bevel Needles, Blunt Fill Needles), End User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 196 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

ÁÖ»ç¹Ù´Ã ½ÃÀåÀÇ 2023³â ½ÃÀå ±Ô¸ð´Â 8¾ï 2,192¸¸ ´Þ·¯·Î 2024³â¿¡´Â 8¾ï 7,017¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, CAGR 5.96%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 12¾ï 3,295¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¹Ù´Ã ½ÃÀåÀº ÀÇ·á, ÀÚ¼ö, ¼¶À¯ Á¦Á¶ µî ´Ù¾çÇÑ ºÐ¾ß¿¡¼­ Æø³Ð°Ô Ȱ¿ëµÇ°í ÀÖ½À´Ï´Ù. ÀÇ·á ±â¼úÀÇ ¹ßÀü, È¿À²ÀûÀÎ ¾à¹°Àü´Þ ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, Á¤±âÀûÀÎ ÀÇ·á °³ÀÔÀÌ ÇÊ¿äÇÑ ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡°¡ ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¾à¹° Åõ¿©ÀÇ ¾ÈÀü¼º°ú Á¤È®¼ºÀ» Æ÷ÇÔÇÑ ¾à¹°Àü´Þ ±â¼ú Çõ½ÅÀÇ Çʿ伺ÀÌ ÀÇ·á¿ë ÁÖ»ç¹Ù´Ã ºÐ¾ßÀÇ ¼ºÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. µ¿½Ã¿¡ ÀÚ¼ö ¹× ¼¶À¯ ¹Ù´Ã ½ÃÀåÀº ¼ö°ø¿¹ Ȱµ¿ÀÇ ºÎȰ°ú ¸ÂÃãÇü ¼¶À¯ Á¦Ç°¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ °ü½É Áõ°¡·Î ÀÎÇØ ¹øÃ¢Çϰí ÀÖ½À´Ï´Ù. ÃÖÁ¾ ¿ëµµ´Â º´¿ø, Ŭ¸®´Ð, ÀçÅà °£È£, ¼¶À¯ »ê¾÷ µî ´Ù¾çÇϱ⠶§¹®¿¡ ÀÌ ½ÃÀåÀº ±¤¹üÀ§ÇÏ°í ¿ªµ¿ÀûÀÎ ½ÃÀåÀ¸·Î ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ÁÖ¿ä ¼ºÀå ¿äÀÎÀ¸·Î´Â »õ·Î¿î µðÀÚÀΰú ¼ÒÀ縦 ¸¸µé¾î³»´Â ±â¼ú ¹ßÀü, ÃÖ¼Òħ½À ¼ö¼úÀÇ ±ÞÁõ, ÀÇ·á ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡ µîÀ» µé ¼ö ÀÖ½À´Ï´Ù. ½Ç½Ã°£ µ¥ÀÌÅÍ ¼öÁýÀ» À§ÇÑ ¼¾¼­¿Í ÅëÇÕµÈ ½º¸¶Æ® ¹Ù´ÃÀÇ °³¹ßÀº ÇコÄÉ¾î ºÐ¾ß¿¡¼­ Å« ÀáÀç·ÂÀ» Á¦°øÇÏ´Â »õ·Î¿î ±âȸ·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ½ÃÀå ¼ºÀå¿¡´Â ³ôÀº ÀÚ»ó À§Çè, ¾ö°ÝÇÑ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©, °æ±¸ ¶Ç´Â °æÇÇ ÆÐÄ¡¿Í °°Àº ´ëü ¾à¹°Àü´Þ ¹æ¹ý°úÀÇ °æÀï µî ¿©·¯ °¡Áö Á¦¾àÀÌ Á¸ÀçÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Á¦¾à¿¡µµ ºÒ±¸Çϰí, °Ç°­ À§Çè°ú ȯ°æ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» ÁÙÀ̱â À§ÇØ Ã·´Ü ¾ÈÀü ¹Ù´Ã°ú ģȯ°æ ÀÏȸ¿ë ¹Ù´ÃÀÇ °³¹ßÀº ±â¼ú Çõ½ÅÀÇ ¸ð¸àÅÒÀ» ³ôÀ̰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, »ýºÐÇØ¼º ¼ÒÀç¿¡ ´ëÇÑ Å½±¸´Â ³Î¸® º¸±ÞµÉ ¼ö ÀÖ´Â ÃÖ÷´Ü Á¦Ç°À» ¸¸µé ¼ö ÀÖ½À´Ï´Ù. ¶Ç ´Ù¸¥ Àü¸ÁÀº µðÁöÅÐ µµ±¸¸¦ Ȱ¿ëÇÏ¿© ÀÚ¼ö ¹Ù´Ã Àû¿ëÀÇ Á¤È®¼º°ú È¿À²¼ºÀ» Çâ»ó½ÃÅ´À¸·Î½á È®´ëµÇ´Â ¸ÂÃãÈ­ Ãß¼¼¸¦ Ȱ¿ëÇÏ´Â °ÍÀÔ´Ï´Ù. 360iResearch´Â Àü·«Àû ÆÄÆ®³Ê½Ê, Áö¼ÓÀûÀÎ R&D ÅõÀÚ, Á¾ÇÕÀûÀÎ ½ÃÀå ºÐ¼®¿¡ ÁßÁ¡À» µÎ°í ¿ªµ¿ÀûÀÎ »óȲÀ» È¿°úÀûÀ¸·Î Ȱ¿ëÇϱâ À§ÇØ Àü·«Àû ÆÄÆ®³Ê½Ê, Áö¼ÓÀûÀÎ R&D ÅõÀÚ, Á¾ÇÕÀûÀÎ ½ÃÀå ºÐ¼®¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. Á¦¾ÈÇϰí ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ[2023] 8¾ï 2,192¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ[2024] 8¾ï 7,017¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ[2030] 12¾ï 3,295¸¸ ´Þ·¯
CAGR(%) 5.96%

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â ÁÖ»ç¹Ù´Ã ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ®¸¦ °ø°³ÇÑ´Ù

ÁÖ»ç¹Ù´Ã ½ÃÀåÀº ¼ö¿ä¿Í °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ëÀ» ÅëÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤, Àü·«Àû ÀÇ»ç°áÁ¤, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ¿ÏÈ­Çϰí, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ÃËÁø¿äÀÎ
    • ¼¼°è ¸¸¼ºÁúȯ Áõ°¡
    • ¼¼°è ³ëÀÎ Àα¸ Áõ°¡¿Í °ü·Ã ÁúȯÀÇ Áõ°¡
    • ½ÅÈï °æÁ¦±¹°¡ÀÇ º´¿ø ¹× Áø·á¼Ò ¼ö Áõ°¡
  • ½ÃÀå ¾ïÁ¦¿äÀÎ
    • ½ºÆ½À¸·Î ÀÎÇÑ ºÎ»ó ¹× °¨¿°¿¡ ´ëÇÑ ¿ì·Á
  • ½ÃÀå ±âȸ
    • ¾ÈÀüÇϰí Á¤¹ÐÇÑ »õ·Î¿î ÁÖ»ç¹Ù´Ã ±â¼úÀ» µµÀÔÇϱâ À§ÇÑ ¿¬±¸°³¹ß ±ÞÁõ
    • ÇåÇ÷¿¡ ´ëÇÑ ÀÎ½Ä Á¦°í¿Í ÇåÇ÷¿¡ ´ëÇÑ Á¤ºÎÀÇ Àû±ØÀû ³ë·Â
  • ½ÃÀå °úÁ¦
    • ´ëü ±â¼ú °³¹ßÀ» µÑ·¯½Ñ ¹®Á¦

Porter's Five Forces : ÁÖ»ç¹Ù´Ã ½ÃÀå Ž»öÀ» À§ÇÑ Àü·« µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲÀÇ °æÀï »óȲÀ» ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®¸¦ ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ÁÖ»ç¹Ù´Ã ½ÃÀå¿¡ ´ëÇÑ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ÁÖ»ç¹Ù´Ã ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ÁÖ»ç¹Ù´Ã ½ÃÀå¿¡¼­ÀÇ °æÀï »óȲ ÆÄ¾Ç

ÁÖ»ç¹Ù´Ã ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­ ¹× ÅëÇÕ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÀλçÀÌÆ®¸¦ ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : ÁÖ»ç¹Ù´Ã ½ÃÀå¿¡¼­ÀÇ °ø±Þ¾÷ü ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ÁÖ»ç¹Ù´Ã ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î º¥´õ¸¦ Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ : ÁÖ»ç¹Ù´Ã ½ÃÀå¿¡¼­ ¼º°øÀÇ ±æ ã±â

ÁÖ»ç¹Ù´Ã ½ÃÀå Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖµµ·Ï ÁغñÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï »óȲÀ» öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ÇâÈÄ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº ¾îµðÀΰ¡?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õÀÇ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ÁÖ»ç¹Ù´Ã ½ÃÀå : Á¦Ç°º°

  • äÇ÷ ¹Ù´Ã
  • Ä¡°ú¿ë ¹Ù´Ã
  • ¾È°ú¿ë ¹Ù´Ã
  • Ææ ¹Ù´Ã
  • ºÀÇÕ ¹Ù´Ã

Á¦7Àå ÁÖ»ç¹Ù´Ã ½ÃÀå : À¯Çüº°

  • ¾×Ƽºê ´Ïµé
  • º£º§ ¹Ù´Ã
  • µÐ°¢ ÃæÀü ¹Ù´Ã
  • ±âÁ¸ ¹Ù´Ã
  • ÇÊÅÍ ´Ïµé
  • ÆÐ½Ãºê ´Ïµé
  • ¾ÈÀü ¹Ù´Ã

Á¦8Àå ÁÖ»ç¹Ù´Ã ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • Áø´Ü ¼¾ÅÍ
  • ÀçÅà ÇコÄɾî
  • º´¿ø¡¤Å¬¸®´Ð

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ ÁÖ»ç¹Ù´Ã ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÁÖ»ç¹Ù´Ã ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÁÖ»ç¹Ù´Ã ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®
  • ¿µ±¹

Á¦12Àå °æÀï »óȲ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Hart Enterprises, Inc.
  • Medtronic plc
  • MicroGroup
  • Neotec Medical Industries Pte. Ltd.
  • Nipro Corporation
  • Novo Nordisk A/S
  • Smiths Medical, Inc.
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation
  • Vita Needle Company
ksm 24.11.28

The Needle Market was valued at USD 821.92 million in 2023, expected to reach USD 870.17 million in 2024, and is projected to grow at a CAGR of 5.96%, to USD 1,232.95 million by 2030.

The market for needles encompasses a wide array of applications in sectors such as healthcare, embroidery, and textile manufacturing. It is primarily driven by advancements in medical technology, increasing demand for efficient drug delivery systems, and the rising prevalence of chronic diseases necessitating regular medical intervention. The necessity for innovations in drug delivery technologies, including safety and precision in administering medications, propels the growth of the medical needle sector. Concurrently, the embroidery and textile needle market thrives on the resurgence of craft activities and growing consumer interest in customized textile products. End-use scope ranges across hospitals, clinics, home care settings, and textile industries, making it a broad and dynamic market. Major growth influencers include technological advancements resulting in novel needle designs and materials, an upsurge in minimally invasive procedures, and increasing investments in healthcare infrastructure. An emerging opportunity exists in the development of smart needles integrated with sensors for real-time data collection, offering significant potential in the healthcare sector. However, market growth faces challenges such as the high risk of needle-stick injuries, stringent regulatory frameworks, and competition from alternative drug delivery methods like oral or transdermal patches. As these limitations loom, an area ripe for innovation lies within the development of advanced safety needles and eco-friendly disposable needles to mitigate health risks and environmental impact. Additionally, exploring biodegradable materials could yield cutting-edge products with broad appeal. Another prospect is leveraging digital tools to enhance the precision and efficiency of embroidery needle applications, thereby capitalizing on growing customization trends. The market's nature is highly competitive, with a continuous push toward integrating advanced technologies and sustainability to meet evolving consumer and regulatory expectations. 360iResearch suggests focusing on strategic partnerships, continuous R&D investments, and comprehensive market analysis to navigate and capitalize on the dynamic landscape effectively.

KEY MARKET STATISTICS
Base Year [2023] USD 821.92 million
Estimated Year [2024] USD 870.17 million
Forecast Year [2030] USD 1,232.95 million
CAGR (%) 5.96%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Needle Market

The Needle Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing incidence of chronic diseases globally
    • Rising elderly population and related diseases worldwide
    • Rising number of hospitals and clinics in developing economies
  • Market Restraints
    • Concerns over needle stick injuries and infections
  • Market Opportunities
    • Surge in research and development to introduce new needle technologies with safety and precision
    • Growing awareness on blood donation and favorable government initiatives for donation
  • Market Challenges
    • Issues over development of alternative technology

Porter's Five Forces: A Strategic Tool for Navigating the Needle Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Needle Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Needle Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Needle Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Needle Market

A detailed market share analysis in the Needle Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Needle Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Needle Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Needle Market

A strategic analysis of the Needle Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Needle Market, highlighting leading vendors and their innovative profiles. These include B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, Cardinal Health, Inc., Hart Enterprises, Inc., Medtronic plc, MicroGroup, Neotec Medical Industries Pte. Ltd., Nipro Corporation, Novo Nordisk A/S, Smiths Medical, Inc., Stryker Corporation, Teleflex Incorporated, Terumo Corporation, and Vita Needle Company.

Market Segmentation & Coverage

This research report categorizes the Needle Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Blood Collection Needles, Dental Needles, Ophthalmic Needles, Pen Needles, and Suture Needles.
  • Based on Type, market is studied across Active Needles, Bevel Needles, Blunt Fill Needles, Conventional Needles, Filter Needles, Passive Needles, and Safety Needles.
  • Based on End User, market is studied across Diagnostic Centers, Home Healthcare, and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidence of chronic diseases globally
      • 5.1.1.2. Rising elderly population and related diseases worldwide
      • 5.1.1.3. Rising number of hospitals and clinics in developing economies
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns over needle stick injuries and infections
    • 5.1.3. Opportunities
      • 5.1.3.1. Surge in research and development to introduce new needle technologies with safety and precision
      • 5.1.3.2. Growing awareness on blood donation and favorable government initiatives for donation
    • 5.1.4. Challenges
      • 5.1.4.1. Issues over development of alternative technology
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Needle Market, by Product

  • 6.1. Introduction
  • 6.2. Blood Collection Needles
  • 6.3. Dental Needles
  • 6.4. Ophthalmic Needles
  • 6.5. Pen Needles
  • 6.6. Suture Needles

7. Needle Market, by Type

  • 7.1. Introduction
  • 7.2. Active Needles
  • 7.3. Bevel Needles
  • 7.4. Blunt Fill Needles
  • 7.5. Conventional Needles
  • 7.6. Filter Needles
  • 7.7. Passive Needles
  • 7.8. Safety Needles

8. Needle Market, by End User

  • 8.1. Introduction
  • 8.2. Diagnostic Centers
  • 8.3. Home Healthcare
  • 8.4. Hospitals & Clinics

9. Americas Needle Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Needle Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Needle Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. B. Braun Melsungen AG
  • 2. Becton, Dickinson and Company
  • 3. Boston Scientific Corporation
  • 4. Cardinal Health, Inc.
  • 5. Hart Enterprises, Inc.
  • 6. Medtronic plc
  • 7. MicroGroup
  • 8. Neotec Medical Industries Pte. Ltd.
  • 9. Nipro Corporation
  • 10. Novo Nordisk A/S
  • 11. Smiths Medical, Inc.
  • 12. Stryker Corporation
  • 13. Teleflex Incorporated
  • 14. Terumo Corporation
  • 15. Vita Needle Company
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦